Continuing donepezil when Alzheimer symptoms worsen might delay nursing home admission, study indicates.
London.
Ingrid
I
Torjesen
D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D000077265:Donepezil; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000627:therapeutic use*; D009735:Nursing Homes / Q000706:statistics & numerical data*; D010343:Patient Admission; D010880:Piperidines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D028761:Withholding Treatment
D002800:Cholinesterase Inhibitors; D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D000077265:Donepezil